Johnson David Michael's Form 4 filing
Aura Biosciences, Inc. (AURA) · filed Dec 15, 2022
- Accession no.
- 0000899243-22-038695
- Filed
- Dec 15, 2022
- Trade date
- Dec 1, 2022
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $123.7K. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnson David MichaelCIK 0001808098 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $12.37 | +$61,850 | 15,000 | Indirect | |
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $12.37 | +$61,850 | 15,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.